Health ❯ Healthcare ❯ Medical Research ❯ Neurology

Alzheimer's Disease

Dual Blood Markers Sharpen Alzheimer’s Diagnosis by Cutting False Positives

A later-stage tau signal helps doctors tell symptomatic Alzheimer’s from early brain changes.

Stories older than 24h

Blood Test Using p‑Tau217 Predicts Dementia Risk in Women Up to 25 Years Before Symptoms

Early Alzheimer’s Markers Identified in Peripheral Retina in Mouse Study

Blood ‘Clock’ Predicts Alzheimer’s Symptom Onset Within 3–4 Years

G-BA Finds No Added Benefit for Alzheimer’s Drug Leqembi in Germany

Anti-Seizure Drug Levetiracetam Blocks Early Alzheimer’s Protein Production, Study Finds

Finger‑Prick Alzheimer’s Blood Test Moves Forward in International Trial With 883 Enrolled

Finger-Prick Blood Spot Test Detects Alzheimer’s Biomarkers With 86% Accuracy

Finger-Prick Dried Blood Test Flags Alzheimer’s Biomarkers in European Study

Largest Blood-Test Study Finds Alzheimer’s Changes Common in Older Adults

Novo Defends Semaglutide Alzheimer’s Strategy After Phase 3 Miss

Novo Nordisk’s Oral Semaglutide Fails to Slow Alzheimer’s in Dual Phase 3 Trials

Shingles Vaccine, Viagra and Riluzole Topped Exeter-Led List for Potential Alzheimer’s Repurposing

Mayo Clinic Model Estimates 10-Year and Lifetime Risk of Cognitive Decline

Alzheimer’s Social Memory Loss Linked to Perineuronal Net Breakdown in Mice

Nature Medicine: p‑tau217 Blood Test Accurately Flags Alzheimer’s on Automated Platform

EU-Cleared Blood Test Forecasts Alzheimer’s Progression as Spain Prepares Therapy Rollout

BioCog Tablet Test Sharpens Primary Care Detection of Cognitive Impairment Linked to Alzheimer’s

UK Launches NHS Trial of £100 Blood Test to Speed Alzheimer’s Diagnosis

3-Minute At-Home EEG ‘Fastball’ Flags Alzheimer’s-Linked Memory Impairment